Skip to content
logo

Softrix NEWS

Connecting You to the World

  • HOME
  • World
  • Business
  • Technology
  • Science
  • Sport
  • Travel
  • US News
  • Food
  • GAMING
  • HEALTH
  • OUR STORE
Pennsylvania Officials Report Fourth Measles Death, as Outbreak Grows
Heart Machine Lays Off 'Nearly Everyone at the Studio' As Unannounced Title is Cancelled
Cleartrip’s New Loyalty Program Is About Reducing ‘Travel Anxiety’
2 terrorists killed in late-night gunfight with security forces in J&K's Udhampur – indiatoday.in
logo

Softrix NEWS

Connecting You to the World

  • HOME
  • World
  • Business
  • Technology
  • Science
  • Sport
  • Travel
  • US News
  • Food
  • GAMING
  • HEALTH
  • OUR STORE
Headlines

Pennsylvania Officials Report Fourth Measles Death, as Outbreak Grows

September 17, 2026

Heart Machine Lays Off 'Nearly Everyone at the Studio' As Unannounced Title is Cancelled

September 17, 2026
Online travel booking top view travel elements collection Scaled

Cleartrip’s New Loyalty Program Is About Reducing ‘Travel Anxiety’

September 17, 2026

2 terrorists killed in late-night gunfight with security forces in J&K's Udhampur – indiatoday.in

September 17, 2026
thermal t

T. rex was as warm-blooded as humans, new study finds

September 17, 2026
1558183 me vote count eat 0010

Fewer than half of Americans expect midterm elections to be 'free and fair,' poll finds

September 17, 2026

GLP-1s and Mental Health: What's Safe to Say to Patients?

September 17, 2026
"15 years ago, people understood it was an unfinished game": As Endless Legend 2 hits 1.0, Amplitude reflect on how early access has changed

"15 years ago, people understood it was an unfinished game": As Endless Legend 2 hits 1.0, Amplitude reflect on how early access has changed

September 17, 2026
f4857df0 b1cc 11f1 b1d1 571ed4d7ff2c

EU chief backs plan for Canada to become 'associate member'

September 17, 2026

Maratha activist Jarange Patil calls off 20-day fast, gives govt 3 months to consider demands – timesofindia.indiatimes.com

September 17, 2026
  • HEALTH

FDA OKs First Drug to Target Muscle Loss in SMA

Saif Al BasharSeptember 14, 202601 mins



Apitegromab is the first SMA therapy to directly target muscle loss and is approved as add-on treatment for patients aged 2 years and older receiving an SMN2-targeted therapy.
Medscape Medical News



Source link

Post navigation

Previous: TCG Card Shop Simulator finally hits 1.0 on Steam after 4 million players, 96% positive reviews, and 2 years in early access
Next: 10-Year Treasury Yield Touches 5%, Highest Level in Years

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related News

Pennsylvania Officials Report Fourth Measles Death, as Outbreak Grows

Saif Al BasharSeptember 17, 2026 0

GLP-1s and Mental Health: What's Safe to Say to Patients?

Saif Al BasharSeptember 17, 2026 0
123030

Trump's Surgeon General Pick Grilled Over Vaccine Stance

Saif Al BasharSeptember 17, 2026 0

Junkins Recalls DHASUWT Hair Dryer Brushes Due to Risk of Serious Injury or Death from Electrocution, and Shock Hazards; Violate Federal Regulations; Smoking and Fire Hazards

Saif Al BasharSeptember 17, 2026 0
  • Home
  • Privacy Policy
  • About us
  • Contact us
logo

Softrix NEWS

Newsmatic - News WordPress Theme 2026. Powered By BlazeThemes.